MacroGenics
MGNX
#9389
Rank
ยฃ65.86 M
Marketcap
ยฃ1.04
Share price
4.14%
Change (1 day)
-61.85%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.11 Billion

According to MacroGenics's latest financial reports the company has ยฃ0.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.16 B-10.91%
2023-12-31ยฃ0.18 B41.39%
2022-12-31ยฃ0.12 B-29.31%
2021-12-31ยฃ0.18 B-9.73%
2020-12-31ยฃ0.19 B21.52%
2019-12-31ยฃ0.16 B-10.31%
2018-12-31ยฃ0.18 B-18.74%
2017-12-31ยฃ0.22 B0.57%
2016-12-31ยฃ0.22 B-1.88%
2015-12-31ยฃ0.22 B126.03%
2014-12-31ยฃ0.10 B43.34%
2013-12-31ยฃ70.61 M139.06%
2012-12-31ยฃ29.53 M-16.85%
2011-12-31ยฃ35.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Xencor
XNCR
ยฃ0.35 B 221.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.26 B 10,135.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.69 B 12,341.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ5.52 B 4,919.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ7.10 B 6,351.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.45 B 6,671.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.40 B 11,172.09%๐Ÿ‡บ๐Ÿ‡ธ USA